Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipid mediators regulating pain sensitivity.

T Philip Malan1, Frank Porreca

  • 1Department of Anesthesiology and Pharmacology, The University of Arizona College of Medicine, P.O. Box 245114, Tucson, AZ 85724-5114, USA. malan@email.arizona.edu

Prostaglandins & Other Lipid Mediators
|August 16, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of a central CGRP circuit for trigeminal V1-mediated migraine-like pain in mice.

Brain : a journal of neurology·2026
Same author

Sexually dimorphic mediation of experimental post-traumatic headache by orexin receptor signaling.

Pain·2026
Same author

Dual Roles of Voltage-gated Calcium Channels and γ-Aminobutyric Acid-mediated Signaling in Modulating Neurotensin Receptor Type 2-induced Antinociception.

Anesthesiology·2026
Same author

Sex-dependent central amygdala physiology after supradural CGRP exposure is associated with migraine-like behaviors.

The journal of headache and pain·2026
Same author

Kappa opioid receptor availability correlates with depressive symptom burden in chronic migraine: a preliminary investigation.

The journal of headache and pain·2026
Same author

Can new understanding of sexually dimorphic pain mechanisms provide a path to improved postoperative pain outcomes in women?

Pain·2026
Same journal

NPY deficiency protects against osteoporosis by altering bone lipid metabolism.

Prostaglandins & other lipid mediators·2026
Same journal

Beyond association: Mediation roles of lipidomics and cytokine in PCOS uncovered by cross-disciplinary genomics.

Prostaglandins & other lipid mediators·2026
Same journal

Aging induces the hepatic CYP4A-20-HETE axis with stage-dependent oxylipin remodeling.

Prostaglandins & other lipid mediators·2026
Same journal

Impact of COX-2 inhibition by DuP-697 on cyclin B1/Cdc2 dynamics in human medullary thyroid carcinoma cells.

Prostaglandins & other lipid mediators·2026
Same journal

Corrigendum to "Pharmacological modulation of NF-κB-dependent COX-2/PGE₂ signaling influences inflammatory lesion development during Leishmania mexicana infection" [Prostaglandins Other Lipid Mediat. 184 (2026) 107075].

Prostaglandins & other lipid mediators·2026
Same journal

Guggulsterone-mediated selective modulation of nuclear receptors: Implications for FXR-PXR signaling and hepatic metabolic homeostasis.

Prostaglandins & other lipid mediators·2026
See all related articles

Lipid molecules are key messengers in the nervous system, regulating pain sensitivity. Some lipids, like acylethanolamides, reduce pain, while others increase it, highlighting their complex role in pain responses.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pharmacology

Background:

  • Lipid molecules are vital messengers in cellular and intercellular communication.
  • Lipid mediators play significant roles in physiological functions, including pain signaling.

Purpose of the Study:

  • To review the role of lipid messengers in regulating pain transmission in the nervous system.
  • To identify specific classes of lipids involved in pain modulation.

Main Methods:

  • Review of existing literature on lipid mediators and pain pathways.
  • Analysis of in vitro and in vivo studies demonstrating lipid interactions with pain signaling systems.

Main Results:

  • Six classes of lipids (prostanoids, phosphatidyl inositol bisphosphate, ceramide, lipoxygenase metabolites of arachidonic acid, fatty acyl dopamines, acylethanolamides) modulate pain sensitivity.

Related Experiment Videos

  • Lipid mediators act via diverse receptor systems.
  • Acylethanolamides inhibit pain, while other lipid classes enhance pain sensitivity.

    • Conclusions:

    • Lipid molecules are crucial regulators of pain sensitivity.
    • Further research in lipidomics will likely uncover additional lipid mediators involved in pain responses.
    • Understanding these lipid pathways offers potential therapeutic targets for pain management.